JPRN-jRCT2092220312已完成3 期
Clinical evaluation of the first domestically developed semi-custom made stent for cerebral aneurysms based on the computational fluid dynamics - PEN001
PEN001 Clinical Trial Office0 个研究点目标入组 19 人开始时间: 2017年10月27日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •1) Unruptured wide-neck (neck of 4mm or more or a dome-to-neck ratio of less than 2) intracranial aneurysm with a sac diameter of 5mm or more diagnosed by angiography or CT angiography or MR angiography 1 year prior to informed consent.2) The parent vessel is with a diameter within a range from 2 to 5 mm.3) The aneurysm is difficult to be treated by conventional surgical (clipping or carotid artery bypass) or endovascular procedure (Coil embolization alone).4) Subject is aged between 20 and 80. 5) Subject is willing and able to provide informed consent. 6) Subject is willing and able to comply with protocol follow-up requirements.
排除标准
- •1)Prior ruptured aneurysms. 2)Prior deployment of the other VRD into the cervical or intracranial lesions 4 weeks prior to the study treatment. 3)Multiple aneurysms of 10mm or more. 4)Target aneurysm neck of 22mm or more.5)Target aneurysm is potentially inaccessible for the study device with anatomical or procedural reasons or due to severe vasospasm that is inefficient to pharmacological treatment. 6)Patient with bleeding disorders 7)Patient with contraindication of anticoagulation therapy. 8)Patient with cardiac diseases caused to cardiogenic cerebral embolism (atrial fibrillation, artificial heart valve, AMI within 6 weeks prior to the study treatment, mitral valve stenosis, intracardiac coagulation, bacterial endocarditis, ventricular aneurysm).9)Patient with severe heart failure (Class IV) based on the NYHA classification guidelines. 10)Patient taking warfarin for cardiac disease treatment.11)Patient with long term treatment of steroid hormone (Ointment cream, eyedrop and etc. for skin diseases and steroid for asthma are acceptable).12)Patient with kidney failure (Serum creatinine level of 2.0mg/dL or more).13)Patient with contrast media reactions in past. 14)Patient with allergy to cobalt-chromium alloy and/or platinum.15) Patient with life expectancy of 6 months or less. 16)Pregnant women or women wishing to get pregnant during study.17)Patient with significant severe intracranial artery stenosis caused by cerebral tumors and cerebral arteriovenous malformation.18)Patient who received surgical treatment within 30 days prior to the study treatment which may affects to outcome of the study.19)Patient who enrolled to other clinical studies and/or Post Marketing Surveillance (except clinical experience study) within 6 months prior to the study treatment.20)Patient who would be ineligible in the opinion of the principle investigator and/or other investigators.
研究者
相似试验
已完成
不适用
Computer Detection of Diabetic Retinopathy compared to screening model by remote image readingCTRI/2017/07/009128Carl Zeiss India Pvt Ltd5,000
已完成
不适用
The clinical pilot study for the evaluation of the efficacy and safety of Monascus-fermentation (Monascus-fermented black bean) on reducing body weight and serum total cholesterol obese subjectsKCT0001040Inje University Seoul Paik Hospital30
已完成
不适用
A preliminary safety and efficacy evaluation of direct delivery of autologous bone marrow-derived cells in Egyptian patients with type 1 diabetes mellitusDigestive SystemType 1 diabetes mellitusISRCTN15591075Wadi EL-Neel hospital (JCI)3
终止
不适用
A Single Exposure Clinical Trial to Evaluate the Dose Duration Response of Mometasone Furoate Cream and Vasoconstrictive Activity of MK0887G Topically applied to the skin of Healthy SubjectsACTRN12612001081808Merck Sharp and Dohme Corp, a subsidiary of Merck & Co., Inc.192
已完成
3 期
Evaluation of the efficacy of defroxamine- deferiprone on cardiac function in patients with thalassemia majorThalassemia major.Beta thalassemia majorIRCT2014070512765N4Golestan University of Medical Sciences12